Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,130 | 1,154 | 1,146 | 1,133 | 1,101 |
| Accounts receivable | -245 | -2,881 | -1,585 | -2,580 | -171 |
| Other Working Capital | 0 | -1,573 | -2,825 | -2,796 | 73 |
| Other Operating Activity | -5,639 | -3,027 | -4,252 | -5,156 | -6,097 |
| Operating Cash Flow | $-4,754 | $-6,326 | $-7,516 | $-9,398 | $-5,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 3 | -97 | -5 | -15 |
| Purchase Of Investment | N/A | -395 | 0 | N/A | N/A |
| Sale Of Investment | 0 | 0 | 0 | 0 | 158 |
| Purchase Sale Intangibles | 0 | 0 | 0 | 0 | -250 |
| Other Investing Activity | 0 | 0 | 0 | 12,725 | 0 |
| Investing Cash Flow | $0 | $-393 | $-97 | $12,719 | $-107 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -54 | -50 | -40 | -41 | -12 |
| Common Stock Repurchased | -2,958 | 0 | -217 | -234 | -1,475 |
| Other Financing Activity | 9 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-3,003 | $-50 | $-258 | $-275 | $-1,487 |
| Beginning Cash Position | 16,980 | 23,748 | 31,619 | 28,573 | 35,260 |
| End Cash Position | 9,223 | 16,980 | 23,748 | 31,619 | 28,573 |
| Net Cash Flow | $-7,758 | $-6,768 | $-7,871 | $3,046 | $-6,687 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,754 | -6,326 | -7,516 | -9,398 | -5,093 |
| Capital Expenditure | N/A | N/A | -97 | -5 | -265 |
| Free Cash Flow | -4,754 | -6,326 | -7,613 | -9,403 | -5,358 |